Format

Send to

Choose Destination
Mov Disord. 2006 Jan;21(1):115-6.

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.

Author information

1
Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, University of South Florida, Tampa, Florida 33612, USA. kbarber@hsc.usf.edu

Abstract

We performed a double-blind randomized placebo-controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with bowel habits (NS) and the total SGA (including abdominal discomfort, bothersome constipation, and satisfaction; NS).

PMID:
16142776
DOI:
10.1002/mds.20666
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center